Chemoinformaics analysis of 27-METHYL-1,3-OCTACOSANEDIOL
| Molecular Weight | 440.797 | nRot | 26 |
| Heavy Atom Molecular Weight | 380.317 | nRig | 0 |
| Exact Molecular Weight | 440.459 | nRing | 0 |
| Solubility: LogS | -6.953 | nHRing | 0 |
| Solubility: LogP | 10.799 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 91 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 60 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 90.0416 |
| nHD | 2 | BPOL | 60.1924 |
| QED | 0.131 |
| Synth | 2.423 |
| Natural Product Likeliness | 0.635 |
| NR-PPAR-gamma | 0.269 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.366 |
| HIA | 0.005 |
| CACO-2 | -5.154 |
| MDCK | 0.00000793 |
| BBB | 0.004 |
| PPB | 0.977097 |
| VDSS | 1.992 |
| FU | 0.0124347 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.148 |
| CYP2c19-inh | 0.094 |
| CYP2c19-sub | 0.047 |
| CYP2c9-inh | 0.041 |
| CYP2c9-sub | 0.981 |
| CYP2d6-inh | 0.023 |
| CYP2d6-sub | 0.009 |
| CYP3a4-inh | 0.12 |
| CYP3a4-sub | 0.016 |
| CL | 5.609 |
| T12 | 0.034 |
| hERG | 0.345 |
| Ames | 0.003 |
| ROA | 0.003 |
| SkinSen | 0.978 |
| Carcinogencity | 0.015 |
| EI | 0.915 |
| Respiratory | 0.366 |
| NR-Aromatase | 0.166 |
| Antiviral | No |
| Prediction | 0.565635 |